David Geffen School of Medicine at UCLA
David Geffen School of Medicine at UCLA
Los Angeles, California, United States2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections. | Bacterial Infections and Mycoses, Infections, fungal infectious disease | Recruiting | Phase 3 | 2026-09-14 | NCT06925321 | |
| A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD | cardiovascular disorder, hypertensive disorder, interstitial lung disease, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-02 | NCT07285655 |